Pro-Pharmaceuticals partners with Camargo

Pro-Pharmaceuticals Inc. of Newton said today it has retained an outsourcing services company to help it obtain regulatory approvals for its drug candidate Davanat.

Davanat is a drug-target delivery compound that the Pro-Pharmaceuticals hopes can be brought to market with multiple chemotherapy drugs.

The firm that the company has retained is Camargo Pharmaceutical Services LLC, which according to its website has offices in in Ohio and which specializes in offering outsourcing services for small and mid-sized pharmaceutical and biotech firms.

Pro-Pharmaceuticals said Camargo will "provide it with strategic regulatory support" in submitting applications to the Food and Drug Administration.
(By Chris Reidy, Globe staff)